Skip to main content

Advertisement

Volume 3 Supplement 1

ESICM LIVES 2015

TLQP-21 modulate inflammation and fibrosis in a model of ards

Article metrics

  • 400 Accesses

Introduction

TLQP-21 is a neuropeptide expressed in the brain that is involved in the control of energy homeostasis. In preliminary experiments we have observed that TLQP-21 can modulate macrophage function. In Acute Respiratory Distress Syndrome (ARDS) macrophage seems to play a critical role, contributing to lung remodeling.

Objectives

To explore the therapeutic role of a short analog of TLQP-21 (JMV5656) in an experimental model of ARDS.

Methods

C57/BL6 mice received an instillation of 0.1 M HCl, 2.5 ml/kg into the right bronchus. They were treated with TLQP-21 0.6 mg/kg ip or vehicle control, 2 days before and on the same day of HCl challenge. Respiratory system compliance, blood gas analysis and differential cell counts in a selective bronchoalveolar lavage (BAL) were determined 24 h after HCl. In a parallel experiment mice were observed for 14 days to assess epithelial damage and lung fibrosis.

Results

The treatment with TLQP-21 showed a significant decrease in the number of total cells in BALF, due to a lower recruitment of neutrophils at 24 hour after challenge with HCl, compared to the vehicle group (Figure 1A), with no differences in macrophage number , even if this did not translate in a functional improvement in lung compliance and oxygenation. At day 14 the TLQP-21 group showed an improvement in lung compliance (Figure 1B) and a decrease collagen deposition in lung tissue (Figure 1C).

Figure 1
figure1

TLQP-21 module lung inflammation and fibrosis. A) Lower neutrophil count in the BALF of the right bronchus at 24 hours after HCI. B) At day 14 lung compliance improved. C) Collagen deposition was lower in the mice treated with TLQP-21. * p ≤ 0.05.

Conclusion

TLQP-21 can decrease inflammatory response at an early phase in a mouse model of HCl-induced ARDS, which may modulate lung remodeling at a late phase, preventing a fibrotic evolution. Given these encouraging but not definitive results we aim to furtherassess the potential therapeutic effect of a higher dose of TLQP-21

Author information

Correspondence to F Pozzi.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pozzi, F., Rizzi, L., Zambelli, V. et al. TLQP-21 modulate inflammation and fibrosis in a model of ards. ICMx 3, A562 (2015) doi:10.1186/2197-425X-3-S1-A562

Download citation

Keywords

  • Bronchoalveolar Lavage
  • Acute Respiratory Distress Syndrome
  • Collagen Deposition
  • Vehicle Group
  • Lung Fibrosis